Download Free Sample
Author
Manoj Kumar is a postgraduate in Life Sciences with over seven years of dedicated experience in the fields of anima.....
Livestock Pharmaceuticals Market: By Product, By Animal, By Distribution Channel, and Geography
Livestock Pharmaceuticals Market: By Product, By Animal, By Distribution Channel, and Geography
Livestock Pharmaceuticals Market size was valued at US$ 18.2 billion in 2023 and is expected to reach a value of US$ 30.79 billion by 2028, at a significant CAGR of 7.8% from 2024-2030. Livestock pharmaceuticals market is used to treat various diseases in animals such as infectious diseases, parasitic diseases, and inflammatory diseases among others. Vaccines are administered to livestock for the prevention of various diseases which increase the immunity of the livestock and make animal healthy. Livestock pharmaceuticals can be administered as solids or liquids directly to the livestock or some pharmaceuticals can be mixed with the animal feed.
Livestock pharmaceuticals market growing at a significant CAGR owing to an increase in the R&D activities for the innovation of newer drugs for various livestock diseases. An increase in the prevalence of various livestock diseases, a rise in demand for healthy meat and other livestock products, increase in the farming of aquatic animals might propel the livestock pharmaceuticals market over the forecast period. Acquisitions & mergers, collaborations, and product launching are the strategies followed by the companies to increase their revenue share in the livestock pharmaceuticals market. For instance, in November 2014, Merck Animal Health launched Finadyne a transdermal non-steroidal anti-inflammatory drug used in cattle for the treatment of pyrexia associated with bovine respiratory disease. In addition, in March 2016, Zoetis Inc. inked an agreement with Sanofis Merial unit to diversify the product portfolio and market the vaccines and drugs for dairy cattle in India.
Study Period
2024-2030Base Year
2023CAGR
7.8%Largest Market
North AmericaFastest Growing Market
Europe
Increase in the prevalence of various livestock diseases such as bird flu in poultry, rise in animal welfare expenditure, government initiatives for the animal health management, and rise in demand for healthy meat and other livestock products are anticipated to fuel the livestock pharmaceuticals market. Moreover, rise in disposable income, increase in the awareness about livestock diseases and treatment, and rise in R&D activities for the innovation of newer therapeutics and vaccines might bolster the growth of the market. However, stringent regulatory guidelines for veterinary medicine approval, ban of certain antibiotics used in the animal diseases, poor availability of drugs in the underdeveloped regions, and dearth of skilled veterinary professionals are hampering the growth of the market.
Geographically, livestock pharmaceuticals market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. Increase in the R&D activities for the development of newer drugs by several U.S. pharmaceutical companies, rise in awareness about the veterinary diseases and treatment, increase in the animal welfare expenditure, and rise in product approvals for livestock diseases are anticipated to propel the North America livestock pharmaceuticals market. Europe livestock pharmaceuticals market growth driven by rise in the production of aquatic animals in Norway, Denmark, Ireland, and other European countries, increase in the demand for healthy meat and other livestock products, rise in the disposable income, and increase in the prevalence of zoonotic diseases. However, Asia Pacific livestock pharmaceuticals market growing at significant rate owing to increase in population demanding for quality meat, launching of newer drugs in Asia Pacific region, and industrialization of poultry sector in the region.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 18.2 billion |
|
Market Size in 2028 |
US$ 30.79 billion |
|
Market CAGR |
7.8% |
|
By Drug Class |
|
|
By Disease Type |
|
|
By Route of Administration |
|
|
By Distribution Channel |
|
|
By Region |
|
Download Free Sample Report
The Livestock pharmaceuticals market size was valued at US$ 18.2 billion in 2023
The key segments covered in the livestock pharmaceuticals market are technology, components, application, and end-users.
The Livestock pharmaceuticals market key players are Zoetis Inc. (U.S), Virbac S.A. (France), Vactoquinol S.A. (France), Merck & Co., Inc. (U.S), Bayer AG (Germnay), Boehringer Ingelheim GmbH (Germany), Ceva Santac Animale (France), Eli Lilly and Company (U.S), Hester biosciences (India)
| 1. Executive Summary |
| 2. Global Livestock Pharmaceuticals Market Introduction |
| 2.1. Global Livestock Pharmaceuticals Market Taxonomy |
| 2.2. Global Livestock Pharmaceuticals Market Definitions |
| 2.2.1. Product |
| 2.2.2. Animal |
| 2.2.3. Distribution Channel |
| 3. Global Livestock Pharmaceuticals Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Global Livestock Pharmaceuticals Market Dynamic Factors - Impact Analysis |
| 3.6. Global Livestock Pharmaceuticals Market Competition Landscape |
| 4. Global Livestock Pharmaceuticals Market Analysis, 2019-2023 and Forecast, 2024-2030 |
| 4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Livestock Pharmaceuticals Market, By Product, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 5.1. Anti-infectives/ Antibiotics |
| 5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Parasiticides |
| 5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Reproduction Management |
| 5.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Vaccines |
| 5.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Others |
| 5.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. High-density Polyethylene (HDPE) |
| 5.6.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 6. Global Livestock Pharmaceuticals Market Forecast, By Animal, 2019-2023 and Forecast, 2024-2030 |
| 6.1. Cattle |
| 6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Sheep |
| 6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Goats |
| 6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Swine |
| 6.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Horses |
| 6.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 6.6. Others |
| 6.6.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.6.3. Market Opportunity Analysis |
| 7. Global Livestock Pharmaceuticals Market Forecast, By Region, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia-Pacific |
| 7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Latin America |
| 7.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Middle East and Africa |
| 7.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 7.6. Global Livestock Pharmaceuticals Market - Opportunity Analysis Index, By Product, By Animal, By Distribution Channel and Region, 2024-2030 |
| 8. North America Livestock Pharmaceuticals Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 8.1. Product Type Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1. Anti-infectives/ Antibiotics |
| 8.1.2. Parasiticides |
| 8.1.3. Reproduction Management |
| 8.1.4. Vaccines |
| 8.1.5. Others |
| 8.2. Animal Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 8.2.1. Cattle |
| 8.2.2. Sheep |
| 8.2.3. Goats |
| 8.2.4. Swine |
| 8.2.5. Horses |
| 8.2.6. Others |
| 8.3. Distribution Channel Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 8.3.1. Veterinary Hospitals |
| 8.3.2. veterinary Pharmacies |
| 8.3.3. Others |
| 8.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 8.4.1. USA |
| 8.4.2. Canada |
| 8.5. North America Livestock Pharmaceuticals Market - Opportunity Analysis Index, By Product, By Animal, By Distribution Channel and Country, 2024-2030 |
| 8.6. North America Livestock Pharmaceuticals Market Dynamics Trends |
| 9. Europe Livestock Pharmaceuticals Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 9.1. Product Type Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1. Anti-infectives/ Antibiotics |
| 9.1.2. Parasiticides |
| 9.1.3. Reproduction Management |
| 9.1.4. Vaccines |
| 9.1.5. Others |
| 9.2. Animal Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 9.2.1. Cattle |
| 9.2.2. Sheep |
| 9.2.3. Goats |
| 9.2.4. Swine |
| 9.2.5. Horses |
| 9.2.6. Others |
| 9.3. Distribution Channel Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 9.3.1. Veterinary Hospitals |
| 9.3.2. veterinary Pharmacies |
| 9.3.3. Others |
| 9.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 9.4.1. Germany |
| 9.4.2. UK |
| 9.4.3. France |
| 9.4.4. Spain |
| 9.4.5. Italy |
| 9.4.6. Russia |
| 9.4.7. Poland |
| 9.4.8. Rest of Europe |
| 9.5. Europe Livestock Pharmaceuticals Market - Opportunity Analysis Index, By Raw Material Type, End -Use and Country, 2024-2030 |
| 9.6. Europe Livestock Pharmaceuticals Market Dynamics Trends |
| 10. Asia-Pacific Livestock Pharmaceuticals Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 10.1. Product Type Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Anti-infectives/ Antibiotics |
| 10.1.2. Parasiticides |
| 10.1.3. Reproduction Management |
| 10.1.4. Vaccines |
| 10.1.5. Others |
| 10.2. Animal Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.2.1. Cattle |
| 10.2.2. Sheep |
| 10.2.3. Goats |
| 10.2.4. Swine |
| 10.2.5. Horses |
| 10.2.6. Others |
| 10.3. Distribution Channel Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.3.1. Veterinary Hospitals |
| 10.3.2. veterinary Pharmacies |
| 10.3.3. Others |
| 10.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 10.4.1. Japan |
| 10.4.2. China |
| 10.4.3. India |
| 10.4.4. ASEAN |
| 10.4.5. Australia & New Zealand |
| 10.4.6. Rest of Asia-Pacific |
| 10.5. Asia-Pacific Livestock Pharmaceuticals Market - Opportunity Analysis Index, By Product, By Animal, By Distribution Channel and Country, 2024-2030 |
| 10.6. Asia-Pacific Livestock Pharmaceuticals Market Dynamics Trends |
| 11. Latin America Livestock Pharmaceuticals Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 11.1. Product Type Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Anti-infectives/ Antibiotics |
| 11.1.2. Parasiticides |
| 11.1.3. Reproduction Management |
| 11.1.4. Vaccines |
| 11.1.5. Others |
| 11.2. Animal Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.2.1. Cattle |
| 11.2.2. Sheep |
| 11.2.3. Goats |
| 11.2.4. Swine |
| 11.2.5. Horses |
| 11.2.6. Others |
| 11.3. Distribution Channel Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.3.1. Veterinary Hospitals |
| 11.3.2. veterinary Pharmacies |
| 11.3.3. Others |
| 11.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 11.4.1. Brazil |
| 11.4.2. Mexico |
| 11.4.3. Argentina |
| 11.4.4. Rest of Latin America |
| 11.5. Latin America Livestock Pharmaceuticals Market - Opportunity Analysis Index, By Product, By Animal, By Distribution Channel and Country, 2024-2030 |
| 11.6. Latin America Livestock Pharmaceuticals Market Dynamics Trends |
| 12. Middle East and Africa Livestock Pharmaceuticals Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 12.1. Product Type Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Anti-infectives/ Antibiotics |
| 12.1.2. Parasiticides |
| 12.1.3. Reproduction Management |
| 12.1.4. Vaccines |
| 12.1.5. Others |
| 12.2. Animal Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.2.1. Cattle |
| 12.2.2. Sheep |
| 12.2.3. Goats |
| 12.2.4. Swine |
| 12.2.5. Horses |
| 12.2.6. Others |
| 12.3. Distribution Channel Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.3.1. Veterinary Hospitals |
| 12.3.2. veterinary Pharmacies |
| 12.3.3. Others |
| 12.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 12.4.1. Gulf Cooperation Council (GCC) Countries |
| 12.4.2. Israel |
| 12.4.3. South Africa |
| 12.4.4. Rest of MEA |
| 12.5. MEA Livestock Pharmaceuticals Market - Opportunity Analysis Index, By Product, By Animal, By Distribution Channel and Country, 2024-2030 |
| 12.6. MEA Livestock Pharmaceuticals Market Dynamics Trends |
| 13. Competition Landscape |
| 13.1. Strategic Dashboard of Top Market Players |
| 13.2. Company Profiles (Introduction, Financial Analysis, Feedstock Material & Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
| 13.2.1. Zoetis Inc. (U.S) |
| 13.2.2. Virbac S.A. (France) |
| 13.2.3. Vétoquinol S.A. (France) |
| 13.2.4. Merck & Co., Inc. (U.S) |
| 13.2.5. Bayer AG (Germnay) |
| 13.2.6. Boehringer Ingelheim GmbH (Germany) |
| 13.2.7. Ceva Santé Animale (France) |
| 13.2.8. Eli Lilly and Company (U.S) |
| 13.2.9. Hester biosciences (India) |
| 14. Research Methodology |
| 15. Key Assumptions and Acronyms |
Key Market Players
Author
Manoj Kumar is a postgraduate in Life Sciences with over seven years of dedicated experience in the fields of animal health and agriculture. His passion lies in unraveling the complexities of these domains through rigorous research and practical insights. Manoj Kumar’s journey has been marked by several key achievements: as a market analyst and competitive intelligence expert, he dissects data to provide actionable insights for global clients. Simultaneously, he champions animal healthcare, diagnosing ailments, and designing preventive care strategies. In the realm of agriculture, his focus on sustainable practices, emphasizing crop nutrition, soil health, and precision agriculture. His holistic approach and commitment to advancing science make him a respected figure in the ever-evolving landscape of life sciences.